Posaconazole for Chronic Refractory Coccidioidal Meningitis

Schein, Rebecca; Homans, James; Larsen, Robert A.; Neely, Michael
December 2011
Clinical Infectious Diseases;12/15/2011, Vol. 53 Issue 12, p1252
Academic Journal
Coccidioidal meningitis is a potentially lethal infection. Disease progression while taking fluconazole is a common complication and safe, effective, alternative treatments are limited. Posaconazole therapy resulted in symptomatic and laboratory improvement in 2 patients and clinical improvement in a third patient with chronic, previously unresponsive coccidioidal meningitis.


Related Articles

  • Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Galgiani, John N.; Catanzaro, Antonino; Cloud, Gretchen A.; Johnson, Royce H.; Williams, Paul L.; Mirels, Laurence F.; Nassar, Faris; Lutz, Jon E.; Stevens, David A.; Sharkey, P. Kay; Singh, Vipul R.; Larsen, Robert A.; Delgado, Kathy L.; Flanigan, Cynthia; Rinaldi, Michael G.; Galgiani, J N; Catanzaro, A; Cloud, G A; Johnson, R H; Williams, P L // Annals of Internal Medicine;11/7/2000, Vol. 133 Issue 9, p676 

    Background: In previous open-label noncomparative clinical trials, both fluconazole and itraconazole were effective therapy for progressive forms of coccidioidomycosis.Objective: To determine whether fluconazole or itraconazole is superior for treatment of nonmeningeal...

  • Comparison of the Drugs Fluconazole or Itraconazole To Treat Coccidioidomycosis Infection. Galgiani, J.N.; Catanzaro, A.; Cloud, G.A.; Johnson, R.H.; Williams, P.L.; Mirels, L.F.; Nassar, F.; Lutz, J.E.; Stevens, D.A.; Sharkey, P.K.; Singh, V.R.; Larsen, R.A.; Delgado, K.L.; Flanigan, C.; Rinaldi, M.G. // Annals of Internal Medicine;11/7/2000, Vol. 133 Issue 9, pI-22 

    Presents a summary of the report 'Comparison of oral fluconazole and itraconazole for progressive nonmeningeal coccidioidomycosis. A randomized, double-blind trial,' published in 'Annals of Internal Medicine,' November 7, 2000 issue.

  • Peritoneal Coccidioidomycosis: Case Report and Review. Phillips, Peter; Ford, Bryce // Clinical Infectious Diseases;6/1/2000, Vol. 30 Issue 6, p971 

    Describes a case of coccidioidal peritonitis, a manifestation of coccidioidomycosis, treated with fluconazole. Background information on coccidioidomycosis; Review of related literature; Emergence of antifungals for the treatment of coccidioidomycosis.

  • Coccidioidomycosis of the brain, mimicking en plaque meningioma. Komotar J R; Clatterbuck R E; Komotar, R J; Clatterbuck, R E; Komotar, J R // Journal of Neurology, Neurosurgery & Psychiatry;Jun2003, Vol. 74 Issue 6, p806 

    No abstract available.

  • Development of fluconazole resistance in a series of Candida parapsilosis isolates from a persistent candidemia patient with prolonged antifungal therapy. Li Zhang; Meng Xiao; Watts, Matthew R.; He Wang; Xin Fan; Fanrong Kong; Ying-Chun Xu // BMC Infectious Diseases;Aug2015, Vol. 15 Issue 1, p1 

    Background: Candida parapsilosis was the most common species causing candidemia in the 2010 China Hospital Invasive Fungal Surveillance Net (CHIF-NET) database. Compared to Candida albicans, the description of azole resistance and mechanisms in C. parapsilosis is very limited. We report a...

  • Calcium-Activated-Calcineurin Reduces the In Vitro and In Vivo Sensitivity of Fluconazole to Candida albicans via Rta2p. Yu Jia; Ren-Jie Tang; Lin Wang; Xiang Zhang; Ying Wang; Xin-Ming Jia; Yuan-Ying Jiang; Goldman, Gustavo Henrique // PLoS ONE;Oct2012, Vol. 7 Issue 10, Special section p1 

    Due to the emergence of drug-resistance, first-line therapy with fluconazole (FLC) increasingly resulted in clinical failure for the treatment of candidemia. Our previous studies found that in vitro RTA2 was involved in the calcineurin-mediated resistance to FLC in C. albicans. In this study, we...

  • Epidemiology and Outcomes of Invasive Candidiasis Due to Non-albicans Species of Candida in 2,496 Patients: Data from the Prospective Antifungal Therapy (PATH) Registry 2004–2008. Pfaller, Michael A.; Andes, David R.; Diekema, Daniel J.; Horn, David L.; Reboli, Annette C.; Rotstein, Coleman; Franks, Billy; Azie, Nkechi E. // PLoS ONE;Jul2014, Vol. 9 Issue 7, p1 

    This analysis describes the epidemiology and outcomes of invasive candidiasis caused by non-albicans species of Candida in patients enrolled in the Prospective Antifungal Therapy Alliance (PATH Alliance) registry from 2004 to 2008. A total of 2,496 patients with non-albicans species of Candida...

  • Call for a California Coccidioidomycosis Consortium to Face the Top Ten Challenges Posed by a Recalcitrant Regional Disease. Thompson III, George; Stevens, David; Clemons, Karl; Fierer, Josh; Johnson, Royce; Sykes, Jane; Rutherford, George; Peterson, Michael; Taylor, John; Chaturvedi, Vishnu // Mycopathologia;Feb2015, Vol. 179 Issue 1/2, p1 

    Coccidioidomycosis ('Valley Fever'), caused by the inhalation of the fungus Coccidioides, remains a recalcitrant health problem in large parts of California. The incidence and severity of the disease continues to rise in many parts of the state. In this manuscript, we highlight unanswered...

  • Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease. Salzer, Helmut J.F.; Heyckendorf, Jan; Lange, Christoph; Le, Thuy; Dalcolmo, Margareth P.; Burchard, Gerd; Rolling, Thierry; Cornely, Oliver A.; Schmiedel, Stefan; Libman, Michael; Capone, Domenico // Respiration;Sep2018, Vol. 96 Issue 3, p283 

    Systemic endemic mycoses cause high rates of morbidity and mortality in certain regions of the world and the real impact on global health is not well understood. Diagnosis and management remain challenging, especially in low-prevalence settings, where disease awareness is lacking. The main...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics